During the last session, CureVac N.V (NASDAQ:CVAC)’s traded shares were 1.01 million, with the beta value of the company hitting 2.50. At the end of the trading day, the stock’s price was $5.49, reflecting an intraday loss of -0.18% or -$0.01. The 52-week high for the CVAC share is $5.72, that puts it down -4.19 from that peak though still a striking 56.83% gain since the share price plummeted to a 52-week low of $2.37. The company’s market capitalization is $1.24B, and the average intraday trading volume over the past 10 days was 3.39 million shares, and the average trade volume was 1.11 million shares over the past three months.
CureVac N.V (CVAC) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.43. CVAC has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it.
CureVac N.V (NASDAQ:CVAC) trade information
CureVac N.V (CVAC) registered a -0.18% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -0.18% in intraday trading to $5.49, hitting a weekly high. The stock’s 5-day price performance is 34.89%, and it has moved by 41.86% in 30 days. Based on these gigs, the overall price performance for the year is 49.59%. The short interest in CureVac N.V (NASDAQ:CVAC) is 4.2 million shares and it means that shorts have 5.55 day(s) to cover.
The consensus price target of analysts on Wall Street is $5, which implies a decrease of -9.8% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $5 and $5 respectively. As a result, CVAC is trading at a premium of 8.93% off the target high and 8.93% off the low.
While earnings are projected to return -165.09% in 2025.
CVAC Dividends
CureVac N.V is due to release its next quarterly earnings on 2025-May-20. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
CureVac N.V (NASDAQ:CVAC)’s Major holders
CureVac N.V insiders own 57.37% of total outstanding shares while institutional holders control 4.71%, with the float percentage being 11.04%. MILLENNIUM MANAGEMENT LLC is the largest shareholder of the company, while 129.0 institutions own stock in it. As of 2024-06-30, the company held over 2.87 million shares (or 1.2808% of all shares), a total value of $9.77 million in shares.
The next largest institutional holding, with 2.42 million shares, is of POINT72 ASSET MANAGEMENT, L.P.’s that is approximately 1.0801% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $8.24 million.